Home   >   Trastuzumab emtansine
Trastuzumab emtansine Chemical Structure

Trastuzumab emtansine

Data Sheet For research use only. Not for human use.
Cat. No. :BCP30527CAS No. :1018448-65-1Purity:98%
Size Price Stock Quotation Inquiry
1.00 mg Get quote In-stock Quotation Inquiry
5.00 mg Get quote In-stock Quotation Inquiry
10.00 mg Get quote In-stock Quotation Inquiry
 Tel: 0086-13026320035   or   orders@biochempartner.com
Real-Time Inquiry ×

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Inquiry Online ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Bulk Inquiry ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

  • Publications Citing of Biochempartner's Trastuzumab emtansine
  • Chemical Properties&Biological Activity
CAS No. 1018448-65-1 Cat. No. BCP30527
Name Trastuzumab emtansine
Synonyms Ado-trastuzumab emtansine;Kadcyla; trastuzumab-DM1; trastuzumab-MCC-DM1; trastuzumab-MCC-DM1 antibody-drug conjugate; T-DM1; PRO132365;
SMILES
Chemical Name
Formula M. Wt 148.5 kg/mol
Purity 98% Storage Store at 4-8°C
Description Trastuzumab emtansine is an antibody-drug conjugate (ADC) consisting of the recombinant anti-epidermal growth factor receptor 2 (HER2) monoclonal antibody trastuzumab conjugated to the maytansinoid DM1 via a nonreducible thioether linkage (MCC) with potential antineoplastic activity. The trastuzumab moiety of this ADC binds to HER2 on tumor cell surface surfaces; upon internalization, the DM1 moiety is released and binds to tubulin, thereby disrupting microtubule assembly/disassembly dynamics and inhibiting cell division and the proliferation of cancer cells that overexpress HER2. Linkage of antibody and drug through a nonreducible linker has been reported to contribute to the improved efficacy and reduced toxicity of this ADC compared to similar ADCs constructed with reducible linkers. Check for active clinical trials or closed clinical trials using this agent.
  • Quality Control&Technical Support
In the process of purchasing and using Biochempartner products, you can consult us if you have any problems: orders@biochempartner.com. We will try our best to solve all your doubts.

Recommend Products

More >

Tags:Trastuzumab emtansine supplier,Trastuzumab emtansine purchase,Trastuzumab emtansine manufacturer,Trastuzumab emtansine distributor,Trastuzumab emtansine cost,Trastuzumab emtansine buy,Trastuzumab emtansine for sale

0086-13720134139